Skip to content
Facebook page opens in new windowX page opens in new windowPinterest page opens in new window
HTIC
HTIC

Mon - Fri: 10:00 - 19:00

Sat, Sun: 11:00 - 17:00

001-234-5679

001-987-6543

  • Home
  • About
  • Technology
  • Leadership
  • News
  • Contact
Search:
  • Home
  • About
  • Technology
  • Leadership
  • News
  • Contact

New Study Shows CitH3-Targeting Antibody Reduces Myocardial Injury and Prevents Heart Failure in Preclinical Models

PublicationBy HTICAugust 20, 2025

Humanized Monoclonal Antibody Against Citrullinated Histone H3 Attenuates Myocardial Injury and Prevents Heart Failure in Rodent Models. Weber M, Chen Y, Zhou X, Chun H, Wu D, Park KH, Cai C, Li Y, Ma J, Yang Z.Biomolecules. 2025 Aug 20;15(8):1196. doi: 10.3390/biom15081196.PMID: 40867640 Free PMC article.

©HTIC, inc. 2024. All rights reserved.

Go to Top